Literature DB >> 25740105

Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia.

Veronica Leoni1, Andrea Biondi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25740105      PMCID： PMC4349266          DOI： 10.3324/haematol.2015.124016

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  39 in total

1.  Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

Authors:  H M Kantarjian; S O'Brien; T L Smith; J Cortes; F J Giles; M Beran; S Pierce; Y Huh; M Andreeff; C Koller; C S Ha; M J Keating; S Murphy; E J Freireich
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

2.  Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation.

Authors:  Paolo Anderlini; Sheetal Sheth; Krystal Hicks; Cindy Ippoliti; Sergio Giralt; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2004-12       Impact factor: 5.742

3.  Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Authors:  Barbara Wassmann; Heike Pfeifer; Michael Stadler; Martin Bornhaüser; Gesine Bug; Urban J Scheuring; Patrick Brück; Matthias Stelljes; Rainer Schwerdtfeger; Nadezda Basara; Jolanta Perz; Donald Bunjes; Georg Ledderose; Rolf Mahlberg; Anja Binckebanck; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

4.  The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Seok Lee; Yoo-Jin Kim; Chang-Ki Min; Hee-Je Kim; Ki-Sung Eom; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Blood       Date:  2005-01-18       Impact factor: 22.113

5.  Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

Authors:  Beate Gleissner; Nicola Gökbuget; Claus R Bartram; Bart Janssen; Harald Rieder; Johannes W G Janssen; Christa Fonatsch; Axel Heyll; Dimitris Voliotis; Joachim Beck; Thomas Lipp; Gerd Munzert; Jürgen Maurer; Dieter Hoelzer; Eckhard Thiel
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

Authors:  Deborah A Thomas; Stefan Faderl; Jorge Cortes; Susan O'Brien; Francis J Giles; Steven M Kornblau; Guillermo Garcia-Manero; Michael J Keating; Michael Andreeff; Sima Jeha; Miloslav Beran; Srdan Verstovsek; Sherry Pierce; Laurie Letvak; August Salvado; Richard Champlin; Moshe Talpaz; Hagop Kantarjian
Journal:  Blood       Date:  2003-10-09       Impact factor: 22.113

7.  A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Authors:  Oliver G Ottmann; Brian J Druker; Charles L Sawyers; John M Goldman; Jose Reiffers; Richard T Silver; Sante Tura; Thomas Fischer; Michael W Deininger; Charles A Schiffer; Michele Baccarani; Alois Gratwohl; Andreas Hochhaus; Dieter Hoelzer; Sofia Fernandes-Reese; Insa Gathmann; Renaud Capdeville; Stephen G O'Brien
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

8.  Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.

Authors:  Seok Lee; Dong-Wook Kim; Bin Cho; Yoo-Jin Kim; Yoo-Li Kim; Ji-Yeon Hwang; Yoon-Hee Park; Ho-Jin Shin; Chi-Young Park; Woo-Sung Min; Hack-Ki Kim; Chun-Choo Kim
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

9.  Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.

Authors:  J P Radich; G Gehly; T Gooley; E Bryant; R A Clift; S Collins; S Edmands; J Kirk; A Lee; P Kessler
Journal:  Blood       Date:  1995-05-01       Impact factor: 22.113

10.  Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.

Authors:  Derek L Stirewalt; Katherine A Guthrie; Lan Beppu; Eileen M Bryant; Kris Doney; Ted Gooley; Frederick R Appelbaum; Jerald P Radich
Journal:  Biol Blood Marrow Transplant       Date:  2003-03       Impact factor: 5.742
View more
  17 in total

1.  Prognostic significance of serum progranulin level in de novo adult acute lymphoblastic leukemia patients.

Authors:  Amro M S El-Ghammaz; Mohamed O Azzazi; Nevine Mostafa; Hany M Hegab; Amir A Mahmoud
Journal:  Clin Exp Med       Date:  2020-01-31       Impact factor: 3.984

Review 2.  Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.

Authors:  Sarah K Tasian; Stephen P Hunger
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

3.  Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  Yang Dai; Jingcao Huang; Pu Kuang; Yiguo Hu; Qiang Zeng; Wanhua Zhang; He Li; Fangfang Wang; Tingting Guo; Dan Zhang; Dongni Yi; Yuhuan Zheng; Ting Liu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

4.  Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.

Authors:  Sandra Cantilena; Luca Gasparoli; Deepali Pal; Olaf Heidenreich; Jan-Henning Klusmann; Joost H A Martens; Alexandre Faille; Alan J Warren; Mawar Karsa; Ruby Pandher; Klaartje Somers; Owen Williams; Jasper de Boer
Journal:  Clin Transl Med       Date:  2022-06

Review 5.  Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL).

Authors:  Manisha Agarwal; Rachna Seth; Tathagata Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-03       Impact factor: 0.900

6.  The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.

Authors:  Costanza Zanetti; Rahul Kumar; Joscha Ender; Parimala S Godavarthy; Mark Hartmann; Joschka Hey; Kersten Breuer; Eva S Weissenberger; Valentina R Minciacchi; Christina Karantanou; Zhaohui Gu; Kathryn G Roberts; Markus Metzler; Wendy Stock; Charles G Mullighan; Clara D Bloomfield; Natalie Filmann; Katrin Bankov; Sylvia Hartmann; Robert P Hasserjian; Antony F Cousins; Christina Halsey; Christoph Plass; Daniel B Lipka; Daniela S Krause
Journal:  Blood       Date:  2021-11-11       Impact factor: 22.113

7.  Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.

Authors:  Klaartje Somers; Kathryn Evans; Richard B Lock; Michelle J Henderson; Leanna Cheung; Mawar Karsa; Tara Pritchard; Angelika Kosciolek; Angelika Bongers; Ali El-Ayoubi; Helen Forgham; Shiloh Middlemiss; Chelsea Mayoh; Luke Jones; Mahima Gupta; Ursula R Kees; Olga Chernova; Lioubov Korotchkina; Andrei V Gudkov; Stephen W Erickson; Beverly Teicher; Malcolm A Smith; Murray D Norris; Michelle Haber
Journal:  Leukemia       Date:  2019-12-17       Impact factor: 12.883

8.  Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.

Authors:  Andrea Ghelli Luserna Di Rorà; Ilaria Iacobucci; Enrica Imbrogno; Cristina Papayannidis; Enrico Derenzini; Anna Ferrari; Viviana Guadagnuolo; Valentina Robustelli; Sarah Parisi; Chiara Sartor; Maria Chiara Abbenante; Stefania Paolini; Giovanni Martinelli
Journal:  Oncotarget       Date:  2016-08-16

Review 9.  Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.

Authors:  Kodappully S Siveen; Kirti S Prabhu; Iman W Achkar; Shilpa Kuttikrishnan; Sunitha Shyam; Abdul Q Khan; Maysaloun Merhi; Said Dermime; Shahab Uddin
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

10.  The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.

Authors:  Caterina De Benedittis; Cristina Papayannidis; Claudia Venturi; Maria Chiara Abbenante; Stefania Paolini; Sarah Parisi; Chiara Sartor; Michele Cavo; Giovanni Martinelli; Simona Soverini
Journal:  BMC Cancer       Date:  2017-08-05       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.